Skip to content

Hepatitis C Screening in the Primary Care Setting

Prospective Cohort Study: Hepatitis C Screening in the Primary Care Setting

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03316313
Enrollment
503
Registered
2017-10-20
Start date
2016-06-30
Completion date
2017-04-30
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Keywords

Public Health, Patient Education as Topic, Hepatitis C

Brief summary

The purpose of this study is to determine whether patient education improves Hepatitis C screening in the primary care setting.

Detailed description

Hepatitis C is a chronic, asymptomatic infection that progresses to liver cirrhosis and cancer in the later stages if left untreated. The Centers for Disease Control (CDC) recommends a one-time screening for high risk birth cohort between the years 1945-1965. Prior studies have evaluated methods to improve screening for hepatitis c with focus on increasing awareness in health professionals. Targets included nursing staff and electronic medical records. This study targets providing patients with education resources to see if screening rates improve.

Interventions

DIAGNOSTIC_TESTHepatitis C Antibody

Patients who received a blood test to screen for the Hepatitis C virus.

Sponsors

New York Institute of Technology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 71 Years

Inclusion criteria

* All patients born between the years 1945 and 1965.

Exclusion criteria

* Patients who had already received a prior screening test for Hepatitis C before the office visit.

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients Screened for Hepatitis CJune 2016 to October 2016.Change from baseline in number of patients from high-risk birth cohort screened for Hepatitis C during intervention period.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026